KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Total Non-Current Liabilities (2016 - 2025)

Pfizer (PFE) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $103.1 billion as the latest value for Q2 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 15.17% to $103.1 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $103.1 billion, a 15.17% decrease, with the full-year FY2024 number at $6.2 billion, up 3.45% from a year prior.
  • Total Non-Current Liabilities was $103.1 billion for Q2 2025 at Pfizer, up from $6.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $121.5 billion in Q2 2024 to a low of -$114.2 billion in Q2 2023.
  • A 5-year average of $43.1 billion and a median of $52.8 billion in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: surged 1848.22% in 2022, then crashed 226.03% in 2023.
  • Pfizer's Total Non-Current Liabilities stood at $6.5 billion in 2021, then decreased by 8.26% to $6.0 billion in 2022, then grew by 0.03% to $6.0 billion in 2023, then grew by 3.45% to $6.2 billion in 2024, then surged by 1560.87% to $103.1 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Total Non-Current Liabilities are $103.1 billion (Q2 2025), $6.2 billion (Q4 2024), and $121.0 billion (Q3 2024).